Recruiting NA INTERVENTIONAL 2-arm
NCT07110051
Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
Comparative Study Between Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
Sponsor: National Cancer Institute, Egypt
Conditions
Abdominal Surgeries Nalbuphine Pediatric Cancer Tramadol
Interventions
Nalbuphine Tramadol
Updated 1 time since 2025 Last updated: Aug 6, 2025 Started: Jan 15, 2025 Primary completion: Sep 15, 2025 Completion: Oct 15, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Abdominal Surgeries and Nalbuphine and is currently actively recruiting participants. National Cancer Institute, Egypt leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- National Cancer Institute, Egypt
Data source: National Cancer Institute, Egypt
For direct contact, visit the study record on ClinicalTrials.gov .